JUNO has a CAR-T drug, which the bashers have been saying would make Kevetrin unnecessary.

I don't suppose those bashers will want to retract those statements now, though.

What I say is, the world needs as many different kinds of treatments as possible. Not any one drug is going to work for everyone. I cheer when some drug works against some disease, whether or not a company whose stock I own has a rival drug in development. This is terrible news that JUNO's treatment may be dangerous.

I'm glad that CTIX has been cautious with its clinical trials and we haven't hurt anyone.